Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Titel:
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Auteur:
van den Bent, Martin J Tesileanu, C Mircea S Wick, Wolfgang Sanson, Marc Brandes, Alba Ariela Clement, Paul M Erridge, Sarah Vogelbaum, Michael A Nowak, Anna K Baurain, Jean Français Mason, Warren P Wheeler, Helen Chinot, Olivier L Gill, Sanjeev Griffin, Matthew Rogers, Leland Taal, Walter Rudà , Roberta Weller, Michael McBain, Catherine Reijneveld, Jaap Enting, Roelien H Caparrotti, Francesca Lesimple, Thierry Clenton, Susan Gijtenbeek, Anja Lim, Elizabeth Herrlinger, Ulrich Hau, Peter Dhermain, Frederic de Heer, Iris Aldape, Kenneth Jenkins, Robert B Dubbink, Hendrikus Jan Kros, Johan M Wesseling, Pieter Nuyens, Sarah Golfinopoulos, Vassilis Gorlia, Thierry French, Pim Baumert, Brigitta G